Prosight Management, LP

Holdings History for ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Symbol: ADCT on NYSE
Investment type: Equity / Common Shares, par value CHF 0.08 per share
Latest Disclosed Shares Owned: 8,477,338 shares
Security Ownership %: 6.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Prosight Management, LP ownership in ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)

13 Feb 2026 - Prosight Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,477,338 shares of ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT). This represents 6.8% ownership of the company. In their previous filing dated 13 Nov 2025, Prosight Management, LP had reported owning 7,195,374 shares, indicating an increase of +18%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Prosight Management, LP	6.8%	+17%	$31,366,151	8,477,338	+1,281,964	+18%	$3.70	13G/A	31 Dec 2025	13 Feb 2026, 16:31
Prosight Management, LP	5.8%		$28,781,496	7,195,374			$4.00	13G/A	30 Sep 2025	13 Nov 2025, 19:38

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	6.2%	+0.73%	$29,925,003	8,477,338	+1,005,035	+13%	$3.53	Q4 2025
30 Sep 2025	7.2%	-2.9%	$29,889,212	7,472,303	-2,995,468	-29%	$4.00	Q3 2025
30 Jun 2025	6.8%	+0.6%	$28,053,626	10,467,771	+924,767	+9.7%	$2.68	Q2 2025
31 Mar 2025	4.4%	+0.01%	$13,455,636	9,543,004	+28,004		$1.41	Q1 2025
31 Dec 2024	5.3%	-0.07%	$18,934,850	9,515,000	-121,237	-1.3%	$1.99	Q4 2024
30 Sep 2024	7.7%	+0.05%	$30,354,147	9,636,237	+66,237	+0.69%	$3.15	Q3 2024
30 Jun 2024	9%	+2.2%	$30,241,200	9,570,000	+2,519,700	+36%	$3.16	Q2 2024
31 Mar 2024	8.8%	+0.72%	$31,655,847	7,050,300	+578,500	+8.9%	$4.49	Q1 2024
31 Dec 2023	4.3%	+0.71%	$10,743,188	6,471,800	+1,069,759	+20%	$1.66	Q4 2023
30 Sep 2023	1.5%	-0.05%	$4,845,631	5,402,041	-181,859	-3.3%	$0.90	Q3 2023
30 Jun 2023	3.5%	+1.5%	$12,005,385	5,583,900	+2,326,540	+71%	$2.15	Q2 2023
31 Mar 2023	3%	+2.6%	$6,351,852	3,257,360	+2,794,050	+603%	$1.95	Q1 2023
31 Dec 2022	0.99%	+0.46%	$1,779,110	463,310	+215,680	+87%	$3.84	Q4 2022
30 Sep 2022	0.66%	+0.66%	$1,194,000	247,630	+247,630	NEW	$4.82	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.